Soliven B C, Lange D J, Penn A S, Younger D, Jaretzki A, Lovelace R E, Rowland L P
Department of Neurology, Columbia-Presbyterian Medical Center, College of Physicians and Surgeons, Columbia University, New York, NY.
Neurology. 1988 Apr;38(4):514-7. doi: 10.1212/wnl.38.4.514.
Of 221 patients with myasthenia gravis, 18.5% had no detectable antibodies to acetylcholine receptor. Seven of 14 patients (50%) with only ocular symptoms for more than 2 years were seronegative, and 25 of 145 (17%) patients with generalized myasthenia were seronegative. The clinical characteristics of seronegative patients did not differ from patients with high antibody titers. No seronegative patient had a thymoma, but that difference did not reach statistical significance. Lack of serum antibodies did not preclude favorable response to thymectomy or plasmapheresis.
在221例重症肌无力患者中,18.5%检测不到抗乙酰胆碱受体抗体。14例仅出现眼部症状超过2年的患者中有7例(50%)血清反应阴性,145例全身型重症肌无力患者中有25例(17%)血清反应阴性。血清反应阴性患者的临床特征与抗体滴度高的患者并无差异。血清反应阴性的患者均无胸腺瘤,但这一差异未达到统计学意义。缺乏血清抗体并不排除对胸腺切除术或血浆置换有良好反应。